Abstract
Background and Aims: The development of post-ERCP pancreatitis (PEP) is one of the most serious ERCP-related complications. The reported incidence of PEP varies between 1.6% and 15% due to differences in clinical settings, definitions and study design. Because ERCP procedures for patients with prior sphincterotomy are easy to access bile duct and low risk, patients with intact papilla are important population. Pancreatic ERCP and biliary ERCP are different in significance of pancreatic procedures such as pancreatic contrast injection and pancreatic stenting; therefore we think that they should be discussed separately. The aim of this study was to identify the risk factors and preventive measures for PEP associated with biliary ERCP in patients with intact papilla.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
